A group of 58 donors and guests met recently outside Philadelphia, to listen to updates on current Alzheimerās research. David Shenk, author of The Forgetting, and Dr. Virginia Lee of The University of Pennsylvania spoke about current investigative trends. Local host and IT consultant Cathy Ingham welcomed the group by ...
April 24, 2012
February 3, 2021
Srilakshmi Srivathsan is a senior at a public high school in Indiana. She initiated a project called Defy Dementia as part of a campaign to raise awareness and donations for Alzheimer’s research. Her motivation for choosing Alzheimer’s disease stems from several personal and scientific reasons. First, her great-grandmother suffered from ...
October 1, 2024
In a 2014 interview with The New York Times, Dr. Murali Doraiswamy of Duke University went on the record stating that āthe lack of a viable model for Alzheimerās disease has been the Achillesā heel of the field.ā This quote was featured in an article discussing the breakthrough research from ...
October 6, 2019
The Northbridge Companies, a New England-based senior living provider, held a reception to celebrate its 2016 fund drive for Cure Alzheimerās Fund. āThis cause is very close to our hearts,ā said Wendy Nowokunski, president of the Northbridge Companies. āWhen my partner, Jim Coughlin, and I formed Northbridge we knew we ...
December 13, 2016
In May, Phyllis Rappaport, Co-Founder, Director and Treasurer of Cure Alzheimerās Fund,Ā spoke aboutĀ the organization to a self-selected subgroup of her Boston-area Smith College reunion class. The group welcomed the opportunity to hear more about CureAlzās latest research findings as part of a mini-reunion held at Rappaportās home.Ā Some of the women have ...
August 23, 2017
October 12, 2023 ā Cure Alzheimerās Fund announces Josephine (Jo) Antonellis has been named Chief Financial Officer (CFO) and Julie Harris, Ph.D., has been named Executive Vice President, Research Management for the nonprofit organization. As CFO, Antonellis will be responsible for the financial management of the nonprofit organization, including leadership of ...
November 13, 2023
Tauopathies, neurodegenerative disorders characterized by the presence of tau protein in the brain, are more likely to emerge in individuals harboring the APOE4 gene. Compared to other APOE variants, the expression of APOE4 significantly increases neuronal loss, decreases brain volume, and increases glial inflammatory signals. In the absence of APOE, ...
December 7, 2021
January 30, 2024
May 2, 2024
